$GRBK
Green Brick Partners, Inc. Stock $grbk

$grbk Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000137367019000009 Filed on May 06, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$168.6M	$129.2M
YoY Change	30.55%	28.22%
Cost Of Revenue	$133.3M	$96.53M
YoY Change	38.05%	23.6%
Gross Profit	$35.37M	$32.63M
YoY Change	8.37%	51.79%
Gross Profit Margin	20.97%	25.27%
Selling, General & Admin	$23.07M	$18.13M
YoY Change	27.23%	323.77%
% of Gross Profit	65.22%	55.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$888.0K	$402.0K
YoY Change	120.9%	356.82%
% of Gross Profit	2.51%	1.23%
Operating Expenses	$23.07M	$18.13M
YoY Change	27.23%	323.77%
Operating Profit	$11.38M	$14.51M
YoY Change	-21.54%	25.33%
Interest Expense	$1.800M	$1.500M
YoY Change	20.0%
% of Operating Profit	15.82%	10.34%
Other Income/Expense, Net	$1.627M	$570.0K
YoY Change	185.44%	5.17%
Pretax Income	$15.32M	$16.61M
YoY Change	-7.78%	37.11%
Income Tax	$3.828M	$3.372M
% Of Pretax Income	24.99%	20.3%
Net Earnings	$12.61M	$11.20M
YoY Change	12.51%	80.78%
Net Earnings / Revenue	7.48%	8.67%
Basic Earnings Per Share	$0.25	$0.22
Diluted Earnings Per Share	$0.25	$0.22
COMMON SHARES
Basic Shares Outstanding	50.56M shares	50.58M shares
Diluted Shares Outstanding	50.61M shares	50.72M shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.90M	$34.40M
YoY Change	-30.52%	6.5%
Cash & Equivalents	$26.61M	$38.85M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$690.8M	$528.5M
Prepaid Expenses
Receivables	$2.800M	$1.500M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$717.5M	$564.4M
YoY Change	27.13%	27.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.464M	$2.108M
YoY Change	111.76%	161.86%
Goodwill	$680.0K
YoY Change
Intangibles	$765.0K
YoY Change
Long-Term Investments	$21.84M	$17.65M
YoY Change	23.74%
Other Assets	$20.20M	$32.20M
YoY Change	-37.27%	-53.87%
Total Long-Term Assets	$75.52M	$78.79M
YoY Change	-4.15%	-14.42%
TOTAL ASSETS
Total Short-Term Assets	$717.5M	$564.4M
Total Long-Term Assets	$75.52M	$78.79M
Total Assets	$793.0M	$643.2M
YoY Change	23.29%	20.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.60M	$20.20M
YoY Change	6.93%	54.2%
Accrued Expenses	$35.90M	$16.30M
YoY Change	120.25%	9.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$87.80M	$59.20M
YoY Change	48.31%	31.26%
LONG-TERM LIABILITIES
Long-Term Debt	$216.8M	$144.9M
YoY Change	49.62%	99.31%
Other Long-Term Liabilities	$2.700M	$0.00
YoY Change		-100.0%
Total Long-Term Liabilities	$219.5M	$144.9M
YoY Change	51.48%	77.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$87.80M	$59.20M
Total Long-Term Liabilities	$219.5M	$144.9M
Total Liabilities	$297.1M	$204.1M
YoY Change	45.53%	60.81%
SHAREHOLDERS EQUITY
Retained Earnings	$190.1M	$137.1M
YoY Change	38.67%	17.05%
Common Stock	$291.8M	$291.3M
YoY Change	0.17%	5.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.041M	$0.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$480.9M	$428.4M
YoY Change
Total Liabilities & Shareholders Equity	$793.0M	$643.2M
YoY Change	23.29%	20.57%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	$12.61M	$11.20M
YoY Change	12.51%	80.78%
Depreciation, Depletion And Amortization	$888.0K	$402.0K
YoY Change	120.9%	356.82%
Cash From Operating Activities	-$9.231M	-$20.22M
YoY Change	-54.35%	-222.18%
INVESTING ACTIVITIES
Capital Expenditures	$571.0K	$601.0K
YoY Change	-4.99%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$571.0K	-$601.0K
YoY Change	-4.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$60.00K	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$5.339M	$19.38M
YoY Change	-127.55%	-205.79%
NET CHANGE
Cash From Operating Activities	-$9.231M	-$20.22M
Cash From Investing Activities	-$571.0K	-$601.0K
Cash From Financing Activities	-$5.339M	$19.38M
Net Change In Cash	-$15.14M	-$1.441M
YoY Change	950.73%	-18.59%
FREE CASH FLOW
Cash From Operating Activities	-$9.231M	-$20.22M
Capital Expenditures	$571.0K	$601.0K
Free Cash Flow	-$9.802M	-$20.82M
YoY Change	-52.92%	-225.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001373670
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50675930	shares
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	Green Brick Partners, Inc.
CY2019Q1	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Year Two LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsYearTwo	72595000	USD
CY2018Q4	grbk	Lotsunder Purchase Options Number LotsunderPurchaseOptionsNumber	1843	lot
CY2019Q1	grbk	Lotsunder Purchase Options Number LotsunderPurchaseOptionsNumber	2308	lot
CY2018Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	26091000	USD
CY2019Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	21640000	USD
CY2018Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	4842000	USD
CY2019Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	2774000	USD
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q1	grbk	Earnest Money Depositsand Preacquisition Costs Written Off EarnestMoneyDepositsandPreacquisitionCostsWrittenOff	100000	USD
CY2019Q1	grbk	Earnest Money Depositsand Preacquisition Costs Written Off EarnestMoneyDepositsandPreacquisitionCostsWrittenOff	500000	USD
CY2018Q4	grbk	Equity Method Investment Summarized Financial Information Accounts Payable EquityMethodInvestmentSummarizedFinancialInformationAccountsPayable	2173000	USD
CY2019Q1	grbk	Equity Method Investment Summarized Financial Information Accounts Payable EquityMethodInvestmentSummarizedFinancialInformationAccountsPayable	3717000	USD
CY2018Q4	grbk	Equity Method Investment Summarized Financial Information Accounts Receivable EquityMethodInvestmentSummarizedFinancialInformationAccountsReceivable	1259000	USD
CY2019Q1	grbk	Equity Method Investment Summarized Financial Information Accounts Receivable EquityMethodInvestmentSummarizedFinancialInformationAccountsReceivable	2100000	USD
CY2018Q4	grbk	Equity Method Investment Summarized Financial Information Accrued Expensesand Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationAccruedExpensesandOtherLiabilities	5328000	USD
CY2019Q1	grbk	Equity Method Investment Summarized Financial Information Accrued Expensesand Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationAccruedExpensesandOtherLiabilities	5284000	USD
CY2018Q4	grbk	Equity Method Investment Summarized Financial Information Cash EquityMethodInvestmentSummarizedFinancialInformationCash	14584000	USD
CY2019Q1	grbk	Equity Method Investment Summarized Financial Information Cash EquityMethodInvestmentSummarizedFinancialInformationCash	5831000	USD
CY2018Q4	grbk	Equity Method Investment Summarized Financial Information Inventory EquityMethodInvestmentSummarizedFinancialInformationInventory	44375000	USD
CY2019Q1	grbk	Equity Method Investment Summarized Financial Information Inventory EquityMethodInvestmentSummarizedFinancialInformationInventory	50065000	USD
CY2018Q4	grbk	Equity Method Investment Summarized Financial Information Loans Held For Sale EquityMethodInvestmentSummarizedFinancialInformationLoansHeldForSale	3083000	USD
CY2019Q1	grbk	Equity Method Investment Summarized Financial Information Loans Held For Sale EquityMethodInvestmentSummarizedFinancialInformationLoansHeldForSale	2732000	USD
CY2018Q4	grbk	Equity Method Investment Summarized Financial Information Notes Payable EquityMethodInvestmentSummarizedFinancialInformationNotesPayable	31402000	USD
CY2019Q1	grbk	Equity Method Investment Summarized Financial Information Notes Payable EquityMethodInvestmentSummarizedFinancialInformationNotesPayable	26748000	USD
CY2018Q4	grbk	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	3132000	USD
CY2019Q1	grbk	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	3797000	USD
CY2018Q4	grbk	Equity Method Investments Summarized Financial Information Bonds Receivable EquityMethodInvestmentsSummarizedFinancialInformationBondsReceivable	5864000	USD
CY2019Q1	grbk	Equity Method Investments Summarized Financial Information Bonds Receivable EquityMethodInvestmentsSummarizedFinancialInformationBondsReceivable	5864000	USD
CY2018Q4	grbk	Finished Homesand Homesunder Construction FinishedHomesandHomesunderConstruction	268763000	USD
CY2019Q1	grbk	Finished Homesand Homesunder Construction FinishedHomesandHomesunderConstruction	278593000	USD
CY2019Q1	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Remainderof Fiscal Year LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsRemainderofFiscalYear	107083000	USD
CY2019Q1	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Total LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsTotal	206427000	USD
CY2019Q1	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Year Four LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsYearFour	1970000	USD
CY2019Q1	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Year Three LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsYearThree	24779000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	29201000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	31914000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	289938000	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	290773000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	291299000	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	291271000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	291299000	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	291271000	USD
CY2018Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	412000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	71000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	71000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	96000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	101000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1200000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1248000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1637000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1600000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21000	shares
CY2018Q4	us-gaap	Assets Assets	784026000	USD
CY2019Q1	us-gaap	Assets Assets	793020000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	454000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	3700000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value Low BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow	1400000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2207000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2661000	USD
CY2017Q4	us-gaap	Cash Cash	36684000	USD
CY2018Q1	us-gaap	Cash Cash	34445000	USD
CY2018Q4	us-gaap	Cash Cash	38315000	USD
CY2019Q1	us-gaap	Cash Cash	23873000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40289000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38848000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41755000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26614000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1441000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-15141000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50598901	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50685699	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50719884	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50719884	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50820548	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50820548	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50583128	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50675930	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	506000	USD
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	507000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	507000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	508000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3432000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	7429000	USD
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2018Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	300000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	400000	USD
CY2019Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	96529000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	133262000	USD
CY2018Q4	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	31978000	USD
CY2019Q1	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	30335000	USD
CY2018Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1614000	USD
CY2019Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1478000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	16499000	USD
CY2019Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	17454000	USD
CY2018Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3431000	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-955000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	402000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	888000	USD
CY2018Q4	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	16793000	USD
CY2019Q1	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	13474000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2018Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	761000	USD
CY2019Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	272000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	72297000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	70389000	USD
CY2018Q1	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	30025000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	27317000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	33394000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	34640000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	17741000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	17368000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	38903000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	35749000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	72297000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	70389000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	15653000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	17272000	USD
CY2018Q1	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	3078000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	3780000	USD
CY2018Q1	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	33103000	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	31097000	USD
CY2018Q4	us-gaap	Equity Method Investments EquityMethodInvestments	20269000	USD
CY2019Q1	us-gaap	Equity Method Investments EquityMethodInvestments	21843000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	680000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	680000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	32634000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	35366000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16611000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15319000	USD
CY2018Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1536000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1846000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3372000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3828000	USD
CY2018Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-46000	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2128000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-4451000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-57000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2069000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2179000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2855000	USD
CY2018Q1	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	1251000	USD
CY2019Q1	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-1643000	USD
CY2018Q1	us-gaap	Increase Decrease In Earnest Money Deposits Outstanding IncreaseDecreaseInEarnestMoneyDepositsOutstanding	830000	USD
CY2019Q1	us-gaap	Increase Decrease In Earnest Money Deposits Outstanding IncreaseDecreaseInEarnestMoneyDepositsOutstanding	-3319000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	33802000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21720000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	135000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1601000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	856000	USD
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	765000	USD
CY2018Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2018Q4	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	389000	USD
CY2019Q1	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	391000	USD
CY2018Q4	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	668961000	USD
CY2019Q1	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	690817000	USD
CY2018Q4	us-gaap	Inventory Real Estate InventoryRealEstate	668961000	USD
CY2019Q1	us-gaap	Inventory Real Estate InventoryRealEstate	690817000	USD
CY2018Q4	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	399809000	USD
CY2019Q1	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	411833000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4434000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	558000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	734000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1011000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1235000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	896000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	438000	USD
CY2018Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	2200000	USD
CY2019Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	2200000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	289863000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	297068000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	784026000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	793020000	USD
CY2018Q4	us-gaap	Line Of Credit LineOfCredit	200386000	USD
CY2019Q1	us-gaap	Line Of Credit LineOfCredit	206522000	USD
CY2018Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	200386000	USD
CY2019Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	206522000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	16691000	USD
CY2018Q1	us-gaap	Minority Interest MinorityInterest	10682000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	17281000	USD
CY2019Q1	us-gaap	Minority Interest MinorityInterest	4788000	USD
CY2018Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8045000	USD
CY2019Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	10735000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19381000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5339000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-601000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-571000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20221000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9231000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	11203000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	12605000	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2036000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1114000	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	2036000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-1758000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	644000	USD
CY2018Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	13239000	USD
CY2019Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	10847000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	14505000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	11380000	USD
CY2019Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000	USD
CY2018Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3996000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3877000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0525
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M
CY2018Q4	us-gaap	Other Assets OtherAssets	8681000	USD
CY2019Q1	us-gaap	Other Assets OtherAssets	10258000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	570000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2093000	USD
CY2019Q1	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	1800000	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	60000	USD
CY2018Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	150000	USD
CY2019Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2018Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	412000	USD
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	544000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	601000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	571000	USD
CY2018Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	8045000	USD
CY2019Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	10735000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	38000000	USD
CY2019Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	37000000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	13239000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	11491000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4690000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4464000	USD
CY2017Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	10474000	USD
CY2018Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	11221000	USD
CY2018Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	14780000	USD
CY2019Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	16526000	USD
CY2018Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	881000	USD
CY2019Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	1140000	USD
CY2018Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	1628000	USD
CY2019Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	2886000	USD
CY2018Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	8531000	USD
CY2019Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	10295000	USD
CY2018Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	8531000	USD
CY2019Q1	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	10295000	USD
CY2018Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10000000	USD
CY2019Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	31000000	USD
CY2018Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	12000	USD
CY2019Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2017Q4	us-gaap	Restricted Cash RestrictedCash	3605000	USD
CY2018Q1	us-gaap	Restricted Cash RestrictedCash	4403000	USD
CY2018Q4	us-gaap	Restricted Cash RestrictedCash	3440000	USD
CY2019Q1	us-gaap	Restricted Cash RestrictedCash	2741000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	125903000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	137106000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	177526000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	190131000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	42724000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	33936000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	15476000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	92136000	USD
CY2018Q1	us-gaap	Revenues Revenues	129163000	USD
CY2019Q1	us-gaap	Revenues Revenues	168628000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18129000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23532000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.00
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	160000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.17
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	34000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	34000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	12.00
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	12.00
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	160000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	9.17
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	400000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.49
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.00
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	630000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	500000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	500000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.49
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.49
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	504000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M28D
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	100000	shares
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	100000	shares
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	0	shares
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.00
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.88
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.88
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M28D
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0	shares
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.00
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	485632000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	485657000	USD
CY2019Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	1120000	USD
CY2017Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2018Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	39228	shares
CY2019Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	59116	shares
CY2019Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	100000	USD
CY2018Q1	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	20000	shares
CY2018Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	106026	shares
CY2019Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	159780	shares
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2018Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1081000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1466000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	416347000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	428386000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	468351000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	480869000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	433038000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	439068000	USD
CY2018Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2018Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	136756	shares
CY2019Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	144618	shares
CY2018Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	981000	USD
CY2019Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1041000	USD
CY2019Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	7862	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2018Q1	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	981000	USD
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1041000	USD
CY2019Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	60000	USD
CY2018Q4	us-gaap	Variable Interest Entity Consolidated Assets Not Pledged VariableInterestEntityConsolidatedAssetsNotPledged	76300000	USD
CY2019Q1	us-gaap	Variable Interest Entity Consolidated Assets Not Pledged VariableInterestEntityConsolidatedAssetsNotPledged	79700000	USD
CY2018Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	141000	shares
CY2019Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	42000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50718000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50605000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50577000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50563000	shares
CY2019Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) as set forth in the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) and applicable regulations of the Securities and Exchange Commission (“SEC”), but do not include all of the information and footnotes required for complete financial statements. The condensed consolidated balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> was derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">. In the opinion of management the accompanying unaudited condensed consolidated financial statements for the periods presented reflect all adjustments of a normal, recurring nature necessary to fairly state our financial position, results of operations and cash flows. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the fiscal year ending </font><font style="font-family:inherit;font-size:10pt;">December 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> or subsequent periods.</font></div></div>
CY2019Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Reclassifications</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning in the first quarter of 2019, the Company reclassified its sales commission expenses from cost of residential units to selling, general and administrative expense in the consolidated statements of income in order to be more readily comparable with a majority of its peers. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For a complete set of the Company’s significant accounting policies, refer to Note 1 of the Company’s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">. Changes and additions to significant accounting policies during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> are presented below.</font></div></div>
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management of the Company to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes, including the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001373670-19-000009-index-headers.html	Edgar Link	pending
0001373670-19-000009-index.html	Edgar Link	pending
0001373670-19-000009.txt	Edgar Link	pending
0001373670-19-000009-xbrl.zip	Edgar Link	pending
a331201910-q.htm	Edgar Link	pending
exhibit101grbk20182.htm	Edgar Link	pending
exhibit101grbk20182001.jpg	Edgar Link	pending
exhibit101grbk20182002.jpg	Edgar Link	pending
exhibit101grbk20182003.jpg	Edgar Link	pending
exhibit101grbk20182004.jpg	Edgar Link	pending
exhibit101grbk20182005.jpg	Edgar Link	pending
exhibit311certificationofc.htm	Edgar Link	pending
exhibit312certificationofc.htm	Edgar Link	pending
exhibit321certificationofc.htm	Edgar Link	pending
exhibit322certificationofc.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
grbk-20190331.xml	Edgar Link	completed
grbk-20190331.xsd	Edgar Link	pending
grbk-20190331_cal.xml	Edgar Link	unprocessable
grbk-20190331_def.xml	Edgar Link	unprocessable
grbk-20190331_lab.xml	Edgar Link	unprocessable
grbk-20190331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GRBK
Green Brick Partners, Inc. Stock $grbk

2019 Q1 Form 10-Q Financial Statement

#000137367019000009 Filed on May 06, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRBK Green Brick Partners, Inc. Stock $grbk

2019 Q1 Form 10-Q Financial Statement

#000137367019000009 Filed on May 06, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRBK
Green Brick Partners, Inc. Stock $grbk